Copyright
©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 298-311
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.298
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.298
Table 6 Validity measures for LIV-4
| Cohort | Measure | LIV-4 ≥ 26.5 | LIV-4 ≥ 45.8 |
| Validation Cohort | Sensitivity | 81.3 (73.9, 88.7) | 61.7 (52.5, 70.9) |
| Specificity | 71.2 (65.3, 77.0) | 83.4 (78.6, 88.2) | |
| PPV | 56.9 (49.0, 64.7) | 63.5 (54.2, 72.7) | |
| NPV | 89.1 (84.6, 93.6) | 82.3 (77.4, 87.2) |
- Citation: Lindenmeyer CC, Flocco G, Sanghi V, Lopez R, Kim AJ, Niyazi F, Mehta NA, Kapoor A, Carey WD, Mireles-Cabodevila E, Romero-Marrero C. LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics. World J Hepatol 2020; 12(6): 298-311
- URL: https://www.wjgnet.com/1948-5182/full/v12/i6/298.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i6.298